| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/24/2000 | EP1001812A1 Composition for the transdermal administration of steroid drugs |
| 05/24/2000 | EP1001811A1 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells |
| 05/24/2000 | EP1001809A1 Decreased fat absorption with an anti-lipase antibody |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP1001790A1 Compositions for lubricating and separating tissues and biological membranes |
| 05/24/2000 | EP1001773A1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 05/24/2000 | EP1001772A1 Improved delivery of multiple doses of medications |
| 05/24/2000 | EP1001763A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 05/24/2000 | EP1001759A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 05/24/2000 | EP1001757A1 Fast-acting analgesic |
| 05/24/2000 | EP1001753A1 Low dosed 15-desoxyspergualine preparations |
| 05/24/2000 | EP1001751A1 Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 05/24/2000 | EP1001750A1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 05/24/2000 | EP1001749A1 Proliposome powders for inhalation stabilised by tocopherol |
| 05/24/2000 | EP1001748A1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 05/24/2000 | EP1001747A1 Compositions for nasal administration |
| 05/24/2000 | EP1001746A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 05/24/2000 | EP1001745A1 Artificial tear formulation |
| 05/24/2000 | EP1001744A2 MICROPARTICLES BASED ON HYBRID POLYMERIC MATERIALS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE MOLECULES, A PROCESS FOR PREPARING THE SAME AND THEIR USES FOR $i(IN VIVO) AND $i(IN VITRO) THERAPY, PROPHYLAXIS AND DIAGNOSTICS |
| 05/24/2000 | EP1001743A1 Implants for controlled release of pharmaceutically active principles and method for making same |
| 05/24/2000 | EP1001732A1 Shellac-containing cosmetic product |
| 05/24/2000 | EP0910350A4 Stabilization of sol-gel derived silica-based glass |
| 05/24/2000 | EP0725629B1 Liposomal defensins |
| 05/24/2000 | EP0724452B1 Pharmaceutical composition containing cyclosporine a, a vitamine e derivative and an emulsifier |
| 05/24/2000 | EP0619735B1 Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) |
| 05/24/2000 | CN2379146Y Temp. controlling type self-heating medicinal adhesion |
| 05/24/2000 | CN1254293A Targeted therapeutic delivery of vitamin D compounds |
| 05/24/2000 | CN1254287A Phosphate-binding polymer preparations |
| 05/24/2000 | CN1254281A HIV and cancer treatment |
| 05/24/2000 | CN1254278A Pharmaceutical injection solution containing taxol |
| 05/24/2000 | CN1253831A Baoyuan kidney-strengthening bag |
| 05/24/2000 | CN1253816A Capsule for curing chronic enteritis |
| 05/24/2000 | CN1253811A Ointment for curing rheumatic arthritis and its preparation method |
| 05/24/2000 | CN1253810A Medicine for curing chronic bronchitis and its preparation method |
| 05/24/2000 | CN1253802A Body-building weight-reducing ointment and its preparation method |
| 05/24/2000 | CN1253797A Chiyan yitiexiao plaster for curing acute contagious conjunctivitis and itspreparation method |
| 05/24/2000 | CN1253792A Ointment for radical curing asthma and its preparation method |
| 05/24/2000 | CN1253791A Specific capsule for curing asthma and its preparation method |
| 05/24/2000 | CN1253790A Intelligence-boosting ointment and its preparation method |
| 05/24/2000 | CN1253789A Face-beautifying body-building ointment and its preparation method |
| 05/24/2000 | CN1253788A Quick-acting eye ointment for curing acute contagious conjunctivitis and its preparation method |
| 05/24/2000 | CN1253781A CoA oral preparation for reducing blood fat and its preparation method |
| 05/24/2000 | CN1253774A Antiparasitic composite containing N,N-diethyl-m-toluamide |
| 05/24/2000 | CN1052655C Human relaxin formulation |
| 05/24/2000 | CN1052650C Process for preparing Qingkailing powder injection |
| 05/24/2000 | CN1052648C Repellent analgesic ointment for cancer or tumor |
| 05/24/2000 | CN1052646C Capsule for curing gastropathy and its preparing method |
| 05/24/2000 | CN1052644C Medicine for curing strip scleroma of thrombophlebitis |
| 05/24/2000 | CN1052643C Method for preparing refined male silk moth powder |
| 05/24/2000 | CN1052642C Instant powder made from fresh dendrobe |
| 05/24/2000 | CN1052639C Traditional Chinese medicine capsule for curing rheumatoid arthritis |
| 05/24/2000 | CN1052637C Use of kingcup |
| 05/23/2000 | US6066676 Pharmaceutical composition and methods for using it |
| 05/23/2000 | US6066629 Dry powder; mixture containing lactamase inhibitor |
| 05/23/2000 | US6066624 Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes |
| 05/23/2000 | US6066620 Mixture with surfactant |
| 05/23/2000 | US6066616 Administering octreotide |
| 05/23/2000 | US6066345 Erythritol containing beverage imparting a cooling taste sensation |
| 05/23/2000 | US6066340 Process for the preparation of microspheres containing biologically active components |
| 05/23/2000 | US6066339 Controlled release coating of ammonia methacrylate copolymer |
| 05/23/2000 | US6066337 Aqueous non-hydrolyzed gelatin support and volatilizing agent are dropped, heated and dried; mixing with drug; disintegration |
| 05/23/2000 | US6066336 Drying cholestyramine; blending with lubricant; compressing to elongated cylinders with desired thickness; applying protective coating; easy-to-swallow |
| 05/23/2000 | US6066335 Method of producing effervescent tablets and effervescent tablet |
| 05/23/2000 | US6066334 Polyvinyl acetate, n-vinylpyrrolidone-containing polymer, water swellable agent, and water insoluble dusting agent; high speed release |
| 05/23/2000 | US6066332 Nanoparticles with outer phase of gelatin and/or collagen hydrolyzate |
| 05/23/2000 | US6066331 Solubilizing with mixture of amphiphatic material and solvent; lyophilization |
| 05/23/2000 | US6066328 Cosmetic or dermatological composition comprising an oil-in-water emulsion comprising oily globules with a lamellar liquid crystal coating |
| 05/23/2000 | US6066292 Sterilization process for pharmaceutical suspensions |
| 05/23/2000 | US6066123 Enhancement of bioavailability by use of focused energy delivery to a target tissue |
| 05/23/2000 | CA2253770A1 Pharmaceutical composition comprising bupropion hydrochloride |
| 05/23/2000 | CA2176712C Synthetic membrane vesicles with controlled release of encapsulated biologically active substances |
| 05/23/2000 | CA2048367C Solid oral forms of application containing ifosfamide as active substance |
| 05/23/2000 | CA2021574C Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
| 05/20/2000 | CA2290333A1 Novel non-phospholipid liposomes modified with a ph and temperature sensitive copolymer |
| 05/20/2000 | CA2254554A1 Novel non-phospholipid liposomes modified with a ph and temperature sensitive copolymer |
| 05/18/2000 | WO2000028598A1 Methods for identification and verification |
| 05/18/2000 | WO2000028554A1 Products and methods for brachytherapy |
| 05/18/2000 | WO2000028019A2 Antisense oligomer |
| 05/18/2000 | WO2000027887A2 Cross-linked hyaluronic acids and medical uses thereof |
| 05/18/2000 | WO2000027849A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 05/18/2000 | WO2000027844A1 Process for the preparation of paroxetine hydrochloride |
| 05/18/2000 | WO2000027828A2 2,4-disubstituted triazine derivatives with anti hiv activity |
| 05/18/2000 | WO2000027795A1 Transfection reagents |
| 05/18/2000 | WO2000027456A1 Method of depositing a dry powder and dispensing device |
| 05/18/2000 | WO2000027437A2 Polymer grafting by polysaccharide synthases |
| 05/18/2000 | WO2000027430A2 Composition consisting of influenza virus surface proteins and dispensing device |
| 05/18/2000 | WO2000027419A1 Method for obtaining lyophilized pharmaceutical compositions of recombinant human erythropoietin stable at room temperature |
| 05/18/2000 | WO2000027399A1 Method for preventing scar tissue formation |
| 05/18/2000 | WO2000027398A1 Pharmaceutical moxifloxacin preparation |
| 05/18/2000 | WO2000027393A1 Powders containing tocotrienols, process for producing the same and tablets prepared by compression molding the same |
| 05/18/2000 | WO2000027392A1 Chromone enteric release formulation |
| 05/18/2000 | WO2000027390A1 Ionic silver complex |
| 05/18/2000 | WO2000027389A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 05/18/2000 | WO2000027385A1 Dispersible compositions containing l-dopa ethyl ester |
| 05/18/2000 | WO2000027373A1 Dry powder pharmaceutical formulation |
| 05/18/2000 | WO2000027372A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 05/18/2000 | WO2000027371A1 Composition for the transdermal delivery of lerisetron |
| 05/18/2000 | WO2000027370A1 Controlled release formulation for water soluble drugs |
| 05/18/2000 | WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 05/18/2000 | WO2000027368A1 Particles coated with granulated crystalline ibuprofen |